Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

vorolanib MeSH Supplementary Concept Data 2025


MeSH Supplementary
vorolanib
Unique ID
C000709220
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000709220
Entry Term(s)
CM082
N-((3S)-1-(dimethylcarbamoyl)pyrrolidin-3-yl)-5-((Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide
Pharm Action
Protein Kinase Inhibitors
Registry Numbers
YP8G3I74EL
Heading Mapped to
*Indoles
*Pyrroles
*Pyrrolidines
Frequency
8
Note
multikinase vascular endothelial growth factor (VEGF) receptor/platelet-derived growth factor (PDGF) receptor inhibitor
Source
Oncologist. 2019 Apr;24(4):455-e121.
Date of Entry
2020/07/30
Revision Date
2021/03/23
vorolanib Preferred
N-((3S)-1-(dimethylcarbamoyl)pyrrolidin-3-yl)-5-((Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide Broader
CM082 Narrower
page delivered in 0.005s